History of Prostate Cancer

Patient presents with a history of prostate cancer.  Initial diagnosis was established on [Date of Diagnosis] at the age of [Patient Age at Diagnosis].  The initial prostate-specific antigen (PSA) level at diagnosis was [PSA Value] ngmL.  Gleason score from the initial biopsy was [Gleason Score] ([Primary Gleason Pattern] + [Secondary Gleason Pattern]), indicating [Gleason Grade Group].  Clinical stage at diagnosis was [Clinical TNM Stage].  Initial treatment consisted of [Treatment Modality e.g., radical prostatectomy, radiation therapy, brachytherapy, active surveillance, hormonal therapy].  Surgical pathology, if applicable, revealed [Pathological Findings e.g., positive surgical margins, extraprostatic extension, seminal vesicle invasion, lymph node involvement].  Post-treatment PSA nadir was [PSA Nadir] ngmL achieved on [Date of Nadir].  Current PSA level is [Current PSA Value] ngmL, obtained on [Date of Current PSA].  The patient is currently [Status e.g., in remission, experiencing biochemical recurrence, with metastatic disease].  Current management includes [Current Treatment e.g., active surveillance, hormonal therapy, chemotherapy, radiation therapy, immunotherapy, bisphosphonates].  Patient reports [Symptoms e.g., urinary incontinence, erectile dysfunction, bone pain].  Physical examination revealed [Physical Exam Findings e.g., normal prostate on digital rectal exam, palpable lymphadenopathy].  Assessment: History of prostate cancer, [Current Status].  Plan: Continue [Current Treatment].  Follow-up PSA in [Duration] months.  Refer to [Referral Specialty e.g., medical oncology, radiation oncology, urology] as needed.  Patient education provided regarding prostate cancer management, potential side effects of treatment, and importance of follow-up care.